Medivation Sees Shareholder Ire Over Alzheimer's Drug
A Medivation Inc. shareholder has hit the biopharmaceutical firm and several top executives with a putative securities class action alleging the company misled the investment community about the promise of an...To view the full article, register now.
Already a subscriber? Click here to view full article